GlaxoSmithKline completes transaction to increase its ownership in Theravance Full Text
GlaxoSmithKline, 05/17/2012
GlaxoSmithKline plc and Theravance, Inc. announced that following approval by Theravance, Inc.'s stockholders at their Annual Meeting held on May 2012, and expiration of applicable waiting periods under the US Hart–Scott–Rodino Antitrust Improvements Act of 1976, GSK's acquisition of 10,000,000 shares of Theravance common stock on the terms previously announced on 2 April 2012, has now completed.



